NASDAQ:APLT
Delisted

Applied Therapeutics Stock Signals

etoro logo Buy APLT
*Your capital is at risk
$0.0959
+0 (+0%)
At Close: Apr 28, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Applied Therapeutics Inc.

General

Signal Type Signal Value Data
Score 0.000 60 days ( 0 %
Last Price $0.0959 0 %
Performance History
7 Days
$0.0959 $0.0959
0%
30 Days
$0.0959 $0.0959
0%
12 Mos
$0.392 $0.0959
-75.52%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 54.73
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0959 - $0.0959
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Apr 27, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Feb 17, 2026 - 50 days
Short MA 3 mos Buy Low Feb 02, 2026 - 60 days
Long MA 3 mos Buy Medium Mar 13, 2026 - 32 days
Short/Long MA 3 mos Buy Medium Mar 13, 2026 - 32 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 31.5
Signal Type Signal Value Importance Data
Trend - 12 mos -28.18 % Very High Width: 406.92 %
Pred. range - 12 mos N/A - $0.88 High -100.00 % - 814.42 %
Short MA 12 mos Buy Very High Feb 23, 2026 - 46 days
Long MA 12 mos Sell Very High Nov 12, 2025 - 114 days
Short/Long MA 12 mos Sell Very High Nov 25, 2025 - 105 days
Pivot Long Buy Low Jan 28, 2026 - 63 days
RSI Long Pivot Signal Sell Low Feb 26, 2026 - 43 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT APPLIED THERAPEUTICS INC.
Applied Therapeutics
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE